Expectations trend
FY2027 · fiscal year ending 2027-12-31 · fmp
Kaltura, Inc. (KLTR)
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
$1.48-3.90%
Close 2026-11-05 · 1-day change
NASDAQInformation TechnologySoftware - ApplicationSnapshot 2026-11-05
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
0.05 → 0.04 EPS · FY ending Dec 31, 2027 · 1 analyst
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
Change in the same fiscal period’s mean EPS estimate from Oct 6, 2026 to Nov 5, 2026: (new ÷ prior − 1). Contributor count changed from 2 to 1; this is not the number of analysts revising. The ±10% axis is a display range.
The EPS and P/E reference is not available for KLTR yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Adjusted EBITDA between $13.8M and $15.2M in 2026 | Adjusted EBITDA target is $13.8M to $15.2M. | Intact | adjusted EBITDA falls below $13.8M in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Net loss for the quarter was $5.5 million, and Adjusted EBITDA for the quarter was $5.9 million.” “• Adjusted EBITDA to be in the range of $15.8 million to $17.2 million.” |
Compare these dated observations with the operating requirements above
FY2027 · fiscal year ending 2027-12-31 · fmp
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 9, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a high-risk, loss-making software business with an early-stage improvement thesis, not an established durable compounder. The thesis is in a watch state: recent performance is below its industry group, though it has not freshly broken.
The valuation model shows KLTR at a 1.58 premium to peers, with a medium-confidence expectations gap of 0.25 and a re-rating as the main divergence driver. The priced-in tag is unjustified, but fragility is low; this points to valuation expectations that may be hard to support if execution weakens.
Near term, management is delivering sequential subscription growth, with revenue rising from $43.2 million in the first quarter to $45.6 million in the second, and its 2026 growth guidance remains 1% to 3%. Adjusted EBITDA also rose quarter over quarter, but the full-year goal remains mixed, and the recent signal shifted from mixed to cautious. PathFactory integration is underway; smaller-company scale and recent peer misses add near-term risk.
Over the next few quarters, the thesis depends on maintaining guidance and converting subscription growth into the guided adjusted EBITDA range. A guidance cut would be a meaningful negative, while Fed rate cuts or steadier results and guidance from large technology peers could improve the sector backdrop.
For the 1-3 year view, KLTR has signs of execution progress, but its loss-making status, high risk, premium to peers, and cautious recent signal leave the thesis dependent on continued delivery. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Total revenue grows about 5% in 2026 | A supporting condition in Kaltura, Inc.'s published investment case. The stated target is about 5% revenue growth in 2026. | Intact | total revenue growth falls below 3% in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “Net loss for the quarter was $5.5 million, and Adjusted EBITDA for the quarter was $5.9 million.” “• Adjusted EBITDA to be in the range of $15.8 million to $17.2 million.” Delivery assessment Nov 3, 2026 |
Subscription revenue grows 1-3% in 2026 | A primary condition in Kaltura, Inc.'s published investment case. The stated target is grow subscription revenue by 1-3% in 2026. | Intact | subscription revenue growth falls below 1% in FY26 | Subscription revenue: $45.642M FY2026-Q2; reported segment. Published target: grow subscription revenue by 1-3% in 2026. Annual target cannot be compared with a quarterly or TTM observation. Aug 5, 202645,642,000 USD · source valueLast status assessment Nov 5, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated in 2 of 2 supplied quarters. Management reported: “The Company’s investor presentation for the quarter, which showcases its agentic avatar technology, is available at: https://q2-26-avatar.kaltura.com/ Total revenue for the second quarter was $46.9 million, with subscription revenue of $45.6 million.” “• Subscription Revenue for the second quarter of 2026 was $45.6 million, an increase of 8% compared to $42.4 million for the second quarter of 2025.” Revenue was $46.894 million in 2026-Q2. Delivery assessment Nov 3, 2026 |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
$0.07 → $0.04 · observed estimates
$0.19B → $0.19B · observed estimates
One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.
| Snapshot | EPS | Revenue | EPS / revenue analysts |
|---|---|---|---|
| 2026-07-24 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-07-25 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-07-26 | $0.07 | $192,700,000 | 2 / 2 |
| 2026-07-27 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-07-28 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-07-29 | $0.07 | $192,700,000 | 2 / 2 |
| 2026-07-30 | $0.07 | $192,700,000 | 2 / 2 |
| 2026-07-31 | $0.07 | $192,700,000 | 2 / 2 |
| 2026-08-01 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-08-02 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-08-03 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-08-04 | $0.07 | $192,700,000 | 2 / 2 |
| 2026-08-05 | $0.07 | $192,700,000 | 2 / 2 |
| 2026-08-06 | $0.07 | $192,681,100 | 2 / 2 |
| 2026-08-07 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-08 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-09 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-10 | $0.08 | $191,700,000 | 1 / 2 |
| 2026-08-12 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-13 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-14 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-15 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-16 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-17 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-18 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-19 | $0.07 | $191,440,650 | 1 / 2 |
| 2026-08-20 | $0.05 | $191,700,000 | 2 / 2 |
| 2026-08-21 | $0.05 | $191,700,000 | 2 / 2 |
| 2026-08-22 | $0.05 | $191,700,000 | 2 / 2 |
| 2026-08-23 | $0.05 | $191,700,000 | 2 / 2 |
| 2026-08-24 | $0.05 | $191,700,000 | 2 / 2 |
| 2026-08-25 | $0.05 | $191,700,000 | 2 / 2 |
| 2026-08-26 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-08-27 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-08-28 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-08-29 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-08-30 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-08-31 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-01 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-02 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-03 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-04 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-05 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-06 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-07 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-08 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-09 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-10 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-11 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-12 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-13 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-14 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-15 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-16 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-17 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-18 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-19 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-20 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-21 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-22 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-23 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-24 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-25 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-26 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-27 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-28 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-29 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-09-30 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-01 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-02 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-03 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-04 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-05 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-06 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-07 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-08 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-09 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-10 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-11 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-12 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-13 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-14 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-15 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-16 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-17 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-18 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-19 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-20 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-21 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-22 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-23 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-24 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-25 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-26 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-27 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-28 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-29 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-30 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-10-31 | $0.05 | $191,690,658 | 2 / 2 |
| 2026-11-01 | $0.04 | $192,900,000 | 2 / 2 |
| 2026-11-02 | $0.04 | $192,900,000 | 1 / 1 |
| 2026-11-03 | $0.04 | $192,900,000 | 1 / 1 |
| 2026-11-04 | $0.04 | $192,900,000 | 1 / 1 |
| 2026-11-05 | $0.04 | $192,900,000 | 1 / 1 |
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Latest: 1 Buy / Strong Buy · 0 Hold · 0 Sell / Strong Sell
Recent actions · Oct 7–Nov 5 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 7, 2026–Nov 5, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.